Verix

Company Overview

Snapshot

Founded in September 2003 by Haggay Tsaban and Amir Ashiri, Verix operates with 51–200 employees. The company has secured $15.45 million in total capital across 2 funding rounds from 4 investors. In June 2023, Verix acquired Start-up.ai to enhance its AI capabilities for accelerating brand growth in life science companies.

Business overview

Verix provides SaaS business intelligence solutions designed to optimize commercial operations, particularly for the life sciences industry. Its core technology leverages patented HotSpots technology to integrate external and internal data sources, offering a holistic market view and identifying threats and opportunities. The company's solutions are available across mobile, web, and offline applications, serving field representatives, account managers, and home office teams by integrating with platforms like Salesforce, Cognos, and SAP. Verix operates within the Business Software sector, focusing on data analysis and decision support for enterprise and healthcare clients.

Strategic signal

Verix's acquisition of Start-up.ai in June 2023 signals a strategic move to deepen its artificial intelligence capabilities, particularly for the life sciences sector. This integration is poised to enhance Verix's offerings in leveraging AI to accelerate brand growth, indicating a forward-looking strategy focused on advanced analytics and intelligent automation to deliver more sophisticated commercial optimization solutions to its clients.

Company Intelligence Q&A

What is Verix's primary focus in the life sciences industry?

Verix offers an AI/ML-powered platform that identifies patients likely to benefit from specific therapies and the physicians treating them, optimizing commercial efforts for pharmaceutical companies. This solution aims to drive revenue growth and operational efficiency.

How does Verix support pharmaceutical companies with market insights?

Verix's Therapeutic Landscape Analysis provides pharmaceutical companies with comprehensive insights into disease areas, treatment paradigms, emerging therapies, and competitive activities. This helps optimize R&D, portfolio management, and commercialization strategies.

What was a significant strategic development for Verix in 2023?

In June 2023, Verix acquired Start-up.ai, a move aimed at further enhancing its capabilities to leverage the power of AI to accelerate brand growth for life science companies.

What patent did Verix secure in November 2025?

In November 2025, Verix secured a US patent for its dynamic code technology, which enables intelligent automation within its flagship Tovana platform.

Which companies partnered with Verix to support a prescription medication launch?

In November 2019, Ironshore Pharmaceuticals partnered with Verix to support the launch of a prescription medication.